2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA

Small interfering RNAs (siRNAs) have the potential to treat a broad range of diseases. siRNAs need to be extensively chemically modified to improve their bioavailability, safety, and stability in vivo. However, chemical modifications variably impact target silencing for different siRNA sequences, ma...

Full description

Bibliographic Details
Main Authors: Sarah M. Davis, Jacquelyn Sousa, Lorenc Vangjeli, Matthew R. Hassler, Dimas Echeverria, Emily Knox, Anton A. Turanov, Julia F. Alterman, Anastasia Khvorova
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253120301360
id doaj-3cf7b384e9da47b99cc82dde09b5fe40
record_format Article
spelling doaj-3cf7b384e9da47b99cc82dde09b5fe402020-11-25T03:44:59ZengElsevierMolecular Therapy: Nucleic Acids2162-25312020-09-01212662772′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNASarah M. Davis0Jacquelyn Sousa1Lorenc Vangjeli2Matthew R. Hassler3Dimas Echeverria4Emily Knox5Anton A. Turanov6Julia F. Alterman7Anastasia Khvorova8RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USARNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA; Department of Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA; Corresponding author: Anastasia Khvorova, PhD, RNA Therapeutics Institute, University of Massachusetts Medical School, AS4-1049, 368 Plantation Street, Worcester, MA 01605, USA.Small interfering RNAs (siRNAs) have the potential to treat a broad range of diseases. siRNAs need to be extensively chemically modified to improve their bioavailability, safety, and stability in vivo. However, chemical modifications variably impact target silencing for different siRNA sequences, making the activity of chemically modified siRNA difficult to predict. Here, we systematically evaluated the impact of 3′ terminal modifications (2′-O-methyl versus 2′-fluoro) on guide strands of different length and showed that 3′ terminal 2′-O-methyl modification negatively impacts activity for >60% of siRNA sequences tested but only in the context of 20- and not 19- or 21-nt-long guide strands. These results indicate that sequence, modification pattern, and structure may cooperatively affect target silencing. Interestingly, the introduction of an extra 2′-fluoro modification in the seed region at guide strand position 5, but not 7, may partially compensate for the negative impact of 3′ terminal 2′-O-methyl modification. Molecular modeling analysis suggests that 2′-O-methyl modification may impair guide strand interactions within the PAZ domain of argonaute-2, which may affect target recognition and cleavage, specifically when guide strands are 20-nt long. Our findings emphasize the complex nature of modified RNA-protein interactions and contribute to design principles for chemically modified siRNAs.http://www.sciencedirect.com/science/article/pii/S2162253120301360oligonucleotidesiRNA designsiRNA chemical modificationsRNA-protein interactions
collection DOAJ
language English
format Article
sources DOAJ
author Sarah M. Davis
Jacquelyn Sousa
Lorenc Vangjeli
Matthew R. Hassler
Dimas Echeverria
Emily Knox
Anton A. Turanov
Julia F. Alterman
Anastasia Khvorova
spellingShingle Sarah M. Davis
Jacquelyn Sousa
Lorenc Vangjeli
Matthew R. Hassler
Dimas Echeverria
Emily Knox
Anton A. Turanov
Julia F. Alterman
Anastasia Khvorova
2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
Molecular Therapy: Nucleic Acids
oligonucleotide
siRNA design
siRNA chemical modifications
RNA-protein interactions
author_facet Sarah M. Davis
Jacquelyn Sousa
Lorenc Vangjeli
Matthew R. Hassler
Dimas Echeverria
Emily Knox
Anton A. Turanov
Julia F. Alterman
Anastasia Khvorova
author_sort Sarah M. Davis
title 2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
title_short 2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
title_full 2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
title_fullStr 2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
title_full_unstemmed 2′-O-Methyl at 20-mer Guide Strand 3′ Termini May Negatively Affect Target Silencing Activity of Fully Chemically Modified siRNA
title_sort 2′-o-methyl at 20-mer guide strand 3′ termini may negatively affect target silencing activity of fully chemically modified sirna
publisher Elsevier
series Molecular Therapy: Nucleic Acids
issn 2162-2531
publishDate 2020-09-01
description Small interfering RNAs (siRNAs) have the potential to treat a broad range of diseases. siRNAs need to be extensively chemically modified to improve their bioavailability, safety, and stability in vivo. However, chemical modifications variably impact target silencing for different siRNA sequences, making the activity of chemically modified siRNA difficult to predict. Here, we systematically evaluated the impact of 3′ terminal modifications (2′-O-methyl versus 2′-fluoro) on guide strands of different length and showed that 3′ terminal 2′-O-methyl modification negatively impacts activity for >60% of siRNA sequences tested but only in the context of 20- and not 19- or 21-nt-long guide strands. These results indicate that sequence, modification pattern, and structure may cooperatively affect target silencing. Interestingly, the introduction of an extra 2′-fluoro modification in the seed region at guide strand position 5, but not 7, may partially compensate for the negative impact of 3′ terminal 2′-O-methyl modification. Molecular modeling analysis suggests that 2′-O-methyl modification may impair guide strand interactions within the PAZ domain of argonaute-2, which may affect target recognition and cleavage, specifically when guide strands are 20-nt long. Our findings emphasize the complex nature of modified RNA-protein interactions and contribute to design principles for chemically modified siRNAs.
topic oligonucleotide
siRNA design
siRNA chemical modifications
RNA-protein interactions
url http://www.sciencedirect.com/science/article/pii/S2162253120301360
work_keys_str_mv AT sarahmdavis 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT jacquelynsousa 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT lorencvangjeli 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT matthewrhassler 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT dimasecheverria 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT emilyknox 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT antonaturanov 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT juliafalterman 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
AT anastasiakhvorova 2omethylat20merguidestrand3terminimaynegativelyaffecttargetsilencingactivityoffullychemicallymodifiedsirna
_version_ 1724512276755513344